Rights and permissions
About this article
Cite this article
Doxorubicin plus docetaxel for operable breast cancer. Inpharma Wkly. 1651, 17 (2008). https://doi.org/10.2165/00128413-200816510-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816510-00036